Mettler-Toledo International, Inc. (MTD) vs Natera, Inc. (NTRA)

Mettler-Toledo International, Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $52.4B against $33.6B — 1.6× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Mettler-Toledo International, Inc. trades at 37.6×. Natera, Inc. grew revenue faster over the last twelve months: 37.4% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs −5.66%) and the higher return on invested capital (35.4% vs −8.35%). Across the 20 metrics below, Mettler-Toledo International, Inc. leads on 14 and Natera, Inc. on 6.

Valuation

Metric MTD NTRA Diagnostics & Research median
P/E 37.65 n/m 34.52
P/S 8.16 18.12 4.24
P/B 2,631.36 28.19 3.42
Price to free cash flow 39.06 1,004.35 33.51
EV/EBITDA 27.43 n/m 23.44
EV/Sales 8.66 17.87 5.18
Earnings yield 2.66% (0.31%) (1.50%)
Free cash flow yield 2.56% 0.10% 0.00%

Profitability

Metric MTD NTRA Diagnostics & Research median
Gross margin 60.26% 0.00% 48.32%
Operating margin 28.41% (8.95%) (5.68%)
Net margin 21.91% (5.66%) (4.10%)
Free cash flow margin 20.90% 1.80% 0.00%
Return on equity (736.36%) (10.55%) 0.00%
Return on assets 25.61% (7.21%) (6.05%)
Return on invested capital 35.40% (8.35%) 0.00%

Growth

Metric MTD NTRA Diagnostics & Research median
Revenue growth (TTM) 6.91% 37.43% 8.99%
EPS growth (last fiscal year) 3.88% 0.65% 20.36%
Revenue growth, 5-year CAGR 5.47% 42.61% 7.30%
Net income growth, 5-year CAGR 7.60% 0.00% 0.00%

Health

Metric MTD NTRA Diagnostics & Research median
Debt to equity 164.70 0.04 0.01
Current ratio 1.12 2.81 2.27
Net debt to EBITDA 1.68 3.74 0.68

Dividend

Metric MTD NTRA Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric MTD NTRA Diagnostics & Research median
Market cap 33.64b 52.43b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack